Artificial Cell Constructs TRIZ Cases

See how cultured fibroblasts deposit collagen around an embedded mesh scaffold, creating durabl

Co-cultured PATS cells and lung fibroblasts model alveolar regeneration failure, enabling fibrosis mechanism study and drug screening.

Fully human 158P1D7-targeting ADCs deliver MMAE to tumor cells, improving cancer killing while limiting side effects.

Specific anti-VHH antibodies enable high-affinity nanobody detection, CART cell sorting, and magnetic separation for immunotherapy workflows.

A vinyl alcohol hydrogel culture surface enables liquid-flow cell detachment with minimal enzyme use, helping preserve cell activity in scale-up.

Ribosome biogenesis inhibitors induce reversible cellular quiescence while preserving viability, supporting cell and tissue preservation.

Basal airway stem cells, matrix proteins, and timed Notch inhibition enable functional lung epithelium on decellularized scaffolds for transplantation.

Apical-out organoids expose epithelial surfaces externally, avoiding microinjection and improving uniform, high-throughput invasion studies.

Sequential growth factor and inhibitor control drives pluripotent stem cells into ureteric bud-like tissue for kidney modeling and drug evaluation.

Heparin preprocessing and fucoidan, oleuropein, and VEGF culture conditions raise EPC purity and proliferation for ischemic disease treatment.

Continuous self-calibration updates particle classification ranges in flow cytometry to improve sorting consistency, yield, and purity.

A staged in-vitro protocol improves robust, efficient generation of proximal and distal lung progenitors from pluripotent stem cells.

Caninized antibodies block canine IL-4Rα signaling to deliver faster antipruritic action while reducing skin inflammation and improving barrier function.

Self-assembled 3D immune organoids overcome tissue-source and cell-number limits to generate robust antigen-specific antibodies within 24 hours.